Access Sequencing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Access sequencing program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Access Sequencing Program Today - Breaking & Trending Today

Next Generation Sequencing Market Size Worth $11.7 Billion By 2028: Grand View Research, Inc.


Next Generation Sequencing Market Size Worth $11.7 Billion By 2028: Grand View Research, Inc.
to reach USD 11.7 billion by 2028 registering a
CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utilization of next generation sequencing (NGS) technology for targeted therapies.
Key suggestions from the report:
The oncology application segment accounted for the largest revenue share in 2020 and will retain its dominance throughout the forecast period due to the development and launch of targeted gene panels for oncology ....

United States , South Africa , Saudi Arabia , South Korea , San Francisco , Genomatix Gmb , Kostenloser Wertpapierhandel , Asia Pacific , Sherry James , Automated Library Preparation , Globalaccess Sequencing Program , Perkinelmer Inc , Library Preparation , View Research , Clinical Research , Library Preparation Kits , Crown Bioscience Inc , Roche Ltd , Technology Outlook Revenue , View Research Inc , Reproductive Health , Genetics Inc , Bio Rad Laboratories Inc , Academic Research , Epidemiology Drug Development , Thermo Fisher Scientific Inc ,

Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus Strains


Share this article
Share this article
CARLSBAD, Calif., Jan. 14, 2021 /PRNewswire/  As scientists continue to identify new strains of the SARS-CoV-2 virus, including the B.1.1.7 UK variant that studies suggest is more transmissible, genetic sequencing is being used to track these strains and new ones that are emerging, as well as to trace transmission patterns within communities. Today, Thermo Fisher Scientific announced an extension of its SARS-CoV-2 GlobalAccess Sequencing Program to provide additional units of the Ion Torrent Genexus System and Ion GeneStudio S5 Series sequencers at a subsidized price to further support global COVID-19 research and surveillance.
Understanding the virus s genetic code and new variants is critical to assist with genetic tracing and transmission interruption efforts. Further research is also needed to determine how new strains affect people who are infected and vaccine effectiveness. Thermo Fisher s next-generation sequencing (NGS ....

United Kingdom , Garret Hampton , Mauricio Minotta , Unity Lab Services , Research Panel , Drug Administration , Thermo Fisher , Globalaccess Sequencing Program , Research Use , Thermo Fisher Scientific Inc , Fisher Scientific , European Centre For Disease Prevention , Our Mission , Thermo Fisher Scientific , Access Sequencing Program , Ion Torrent Genexus , European Centre , Disease Prevention , Genexus System , Ion Ampliseq , For Research Use , Thermo Scientific , Applied Biosystems , Contact Information , Public Relations , Health Care Amp Hospitals ,